ASCO Annual Meeting & Conference

Jan 06, 04
18:08 ET	Cell Genesys to Webcast Presentation at the JPMorgan Healthcare Conference
Dec 06, 03
22:09 ET	Cell Genesys Reports Interim Clinical Data From Phase 2 Trial of GVAX(R) Leukemia Vaccine
Dec 04, 03
09:00 ET	Cell Genesys to Webcast Presentation At The Harris Nesbitt Gerard Healthcare Investor Conference
Oct 27, 03
16:02 ET	Cell Genesys Reports Third Quarter Financial Results
Oct 22, 03
09:02 ET	Cell Genesys to Webcast Third Quarter 2003 Conference Call
Oct 16, 03
09:00 ET	Cell Genesys to Webcast Presentation At The Rodman & Renshaw Techvest Healthcare Conference
Jun 19, 03
10:00 ET	Cell Genesys to Webcast Company Presentation from the Bio 2003 Annual Convention
Jun 17, 03
09:04 ET	Randomized Phase III Trial Shows Efficacy of Campath(R) Following Fludarabine in Patients With CLL
Jun 16, 03
10:00 ET	Research Shows Once-Weekly Hycamtin(R) Offers Improved Tolerability for Patients With Ovarian and Peritoneal Cancers
Jun 06, 03
09:00 ET	New Data Presented on Alternative Treatment for Stage IV Melanoma
Jun 05, 03
12:01 ET	Delcath Reports On 2003 Annual Meeting
Jun 04, 03
17:06 ET	New Data from Clinical Trials of QUADRAMET(R) in Hematological and Solid Tumor Cancers Presented at ASCO
11:01 ET	Underutilization of Drugs, Delayed Market Entry Compromise Patient Care and Impact Drug Sales Potential
09:00 ET	Preclinical Results Show Genasense(TM) Synergizes with Campath(R) in Chronic Lymphocytic Leukemia
08:05 ET	Accelerate Brain Cancer Cure (ABC2) Foundation Comments on Genentech's Brain Cancer Trial Results Presented at ASCO
Jun 03, 03
15:01 ET	Isis Pharmaceuticals Provides Summary of American Society of Clinical Oncology Data Presentations on Anti-Cancer Antisense Drugs in Development
11:24 ET	Second Study Confirms Activity of SuperGen's Nipent(R), in Combination Therapy, in Patients With Chronic Lymphocytic Leukemia
10:33 ET	Medarex Announces June 4th Webcast of MDX-010 Clinical Results Following ASCO Conference
09:30 ET	Positive Clinical Data on Satraplatin in the Treatment of Hormone-Refractory Prostate Cancer Presented at ASCO
09:07 ET	Spectrum Pharmaceuticals Reports Positive Clinical Data Presented on Satraplatin in the Treatment of Hormone-Refractory Prostate Cancer at ASCO
09:04 ET	Intermittent Taxotere/Calcitriol Chemotherapy Feasible in Treatment of Advanced Prostate Cancer
09:02 ET	Genasense(TM) Combination With Chemotherapy Reported Useful in Newly Diagnosed Patients With Small Cell Lung Cancer
09:02 ET	Genasense(TM) Plus Taxotere(R) Reported Active in Patients with Hormone-Refractory Prostate Cancer at ASCO Meeting
09:01 ET	Millennium Announces Promising Early Study Results With VELCADE(TM) (bortezomib) For Injection Combined With Doxil in Patients With Advanced Multiple Myeloma
08:15 ET	American Pharmaceutical Partners Announces Positive Results of Intra-Arterial ABI-007 in Phase II Trial in Head and Neck Cancer Patients and in Patients With Cancers of the Pelvis
07:01 ET	TRISENOX(R) Highly Active in Refractory Multiple Myeloma Patients When Combined With Vitamin C and Melphalan
07:00 ET	NeoPharm and Collaborators Present New IL13-PE38QQR Clinical Data In Brain Cancer
Jun 02, 03
15:16 ET	The Susan G. Komen Breast Cancer Foundation Says MRI Is Good News for At-Risk Women But Not Yet Ready for Widespread Use
15:05 ET	Research Confirms Weight Gain and Safety of Anabolic Androgenic Steroid, Oxandrolone, in Patients With Cancer-Related Weight Loss
14:51 ET	Aton Pharma, Inc. Presents Phase I Trial Data of Anti-Cancer Agent SAHA in Patients With Hematological Malignancy at ASCO
14:51 ET	OvaRex(R) Study Demonstrates Clinical Benefit for Ovarian Cancer Patients
14:30 ET	Introgen's Advexin Therapy Halts Tumor Growth in Advanced Esophageal Cancer Patients
14:20 ET	The Addition of Oxaliplatin to Gemcitabine Markedly Enhances Treatment Efficacy in Advanced Pancreas Cancer: Results of the Gem-GemOx Phase III Study
14:09 ET	Major Results on ELOXATIN(TM) (Oxaliplatin for Injection) Presented at the American Society of Clinical Oncology (ASCO)
14:01 ET	Investor Enthusiasm Returns to Biotech in May
13:58 ET	CALGB Presents Clinical Results on BioNumerik Pharmaceuticals' Novel Antitumor Agent at the 39th Annual Meeting Of The American Society of Clinical Oncology (ASCO)
13:51 ET	Cancer Patients With Bone Complications Overwhelmingly Prefer Infusion of Zoledronic Acid Over Pamidronate
13:36 ET	Pharmacyclics Announces Results of RTOG Survival Analysis from Phase 1 Trial With Xcytrin for Primary Brain Tumors
13:28 ET	Millennium Announces Preliminary Phase I and Phase II Findings of VELCADE(TM) (Bortezomib) For Injection in Studies of Non-Hodgkin's Lymphoma and Solid Tumors
12:47 ET	Penwest Pharmaceuticals Announces Endo Has Reported Positive Results In Clinical Study of Oxymorphone ER In Cancer Pain
12:14 ET	New Study Shows RITA Medical Systems Radiofrequency (RF) Technology Increases Survival Rates for Patients With Colorectal Cancer That Spread to the Liver and Beyond
11:43 ET	Fludarabine Phosphate and Alemtuzumab (FluCam) Shows Promise in Treating Patients With Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
11:22 ET	Novel RAF Kinase Inhibitor Bay 43-9006 Shows Early Signs of Tolerability and Activity in Phase Ib Combination Trials Reported at ASCO
10:30 ET	Genomic Health, Inc. Announces Encouraging Results From Clinical Trials Of Genomic Tests to Predict Breast Cancer Recurrence and Response to Chemotherapy And Response to EGFR Inhibitor Therapy in Lung Cancer
10:15 ET	GenOdyssee Presents Pre-Clinical Results of Interferon Alpha Variants for the Treatment of Cancer
10:02 ET	Objective Response Reported in Phase I Trial Using EntreMed's Panzem(R)
10:01 ET	Kosan and Roche Present Favorable Phase I Results of KOS-862 (Epothilone D), at the American Society of Clinical Oncology Annual Meeting
10:01 ET	New Data Suggest Risk of Infection Doubles With Reduced NEUPOGEN(R) Administration
10:01 ET	Yale Researchers Discover That Phenoxodiol Combined With Small Doses Of Chemotherapy Reduces Ovarian Cancer Tumor Mass By 75 Percent; Data Presented Today at ASCO
10:00 ET	New Research Presented at ASCO Shows RDP58 Allowed Increased Dosing of Chemotherapy in Mice Without Increased G.I. Toxicities
10:00 ET	Novel RAF Kinase Inhibitor Bay 43-9006 Shows Early Signs of Tolerability and Activity in Phase Ib Combination Trials Reported at ASCO
09:35 ET	igeneon Presents Cancer Vaccine IGN101 Phase II Data at the Annual American Society of Clinical Oncology (ASCO) Meeting
09:15 ET	The Use of Taxotere(R) in Treating Breast Cancer Highlighted at American Society of Clinical Oncology Annual Meeting
09:05 ET	Vion Presents Clinical Data on Triapine(R) In Combination with Gemcitabine at ASCO(R) Meeting
09:03 ET	Bristol-Myers Squibb Epothilone Phase II Findings Show Activity in Metastatic Breast Cancer and Non-Small Cell Lung Cancer
09:02 ET	American Pharmaceutical Partners Announces Anti-Tumor Activity of ABI-007 In Breast Cancer Patients Resistant to Taxane Therapy
09:02 ET	Cell Genesys Reports Initial Clinical Data From Phase 1/2 Trial of GVAX(R) Myeloma Vaccine
09:02 ET	Cell Genesys Reports Interim Clinical Data From Phase 2 Trial of GVAX(R) Prostate Cancer Vaccine
09:02 ET	Combined Use of TNFerade(TM) and Radiation Therapy Produced 85% Response Rate in Phase I Study of Patients with Soft Tissue Sarcoma
09:00 ET	Taxotere(R) (docetaxel) Injection Concentrate Regimen Shown to Provide Survival Benefits in Advanced Stomach Cancer
08:30 ET	Investigators Report Results of Studies With Point Therapeutics' PT-100, An Anti-Tumor Small Molecule That Amplifies Immunity
08:09 ET	McMaster University Study Shows Cancer Patients Benefit From New Method of Bone Analysis
08:09 ET	Vion Presents Clinical Data on VNP40101M in Leukemia at ASCO(R) Meeting
08:07 ET	EXIMIAS Announces Study Results of THYMITAQ(R) in Patients With Advanced Liver Cancer at ASCO
08:07 ET	EXIMIAS Announces Study Results of THYMITAQ(R) in Patients With Advanced Pancreatic Cancer Presented at ASCO
08:02 ET	Clinical Study Results Show Genasense(TM) May Delay Progression in Patients With Aggressive Non-Hodgkin's Lymphoma
08:01 ET	GenVec Presents Preliminary Dose Escalation Data from Study Combining TNFerade(TM) with Chemotherapy and Radiation in Patients With Locally Advanced Pancreatic Cancer
07:01 ET	XYOTAX(TM) Extends Median Survival for High Risk Lung Cancer Patients
06:00 ET	Exelixis Announces Phase 2 Data on Rebeccamycin Analogue in Hepatobiliary Tumors Presented at ASCO
Jun 01, 03
19:30 ET	Merck KGaA Says Strong Erbitux(TM) (Cetuximab) Data Confirm Value of Targeted Cancer Approach
19:00 ET	Immunomedics Reports on Two Novel Antibodies for B-Cell Tumor Therapy
17:01 ET	Telik Announces Confirmatory Results From Second Phase 2 Trial of TELCYTA(TM) (TLK286) In Advanced Ovarian Cancer
17:01 ET	Telik Announces Confirmatory Results From Second Phase 2 Trial of TELCYTA(TM) In Advanced Non-Small Cell Lung Cancer
16:52 ET	Oxaliplatin Significantly Decreases the Risk of Relapse After Surgery From Colorectal Cancer: Results of the MOSAIC Study
15:24 ET	New Data Show Erbitux(TM) (Cetuximab) Offers Hope for Many Metastatic Colorectal Cancer Patients
14:43 ET	The Susan G. Komen Breast Cancer Foundation Announces Pharmacogenomics Study Results Hold Promise But Need Further Study
14:24 ET	Anti-CEA Monoclonal Antibody Combined With Chemotherapy Demonstrates Positive Preclinical Results in Colon and Breast Cancers
14:21 ET	Bristol-Myers Squibb and ImClone Systems Issue Joint Statement on Merck KGaA -007 Study Data Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
14:00 ET	Study Shows Promising Results for Elderly Patients With Non-Small Cell Lung Cancer Treated With Taxotere(R)-Based Combination Versus Another Standard Therapy
11:30 ET	Phase 3 Data Suggest Palifermin Significantly Reduces the Duration and Incidence of Oral Mucositis in Cancer Patients
10:15 ET	Georgetown Researchers Confirm Safety and Demonstrate First Evidence of Clinical Activity of Therion Biologics' TRICOM(TM) Vaccine in Advanced Cancers
09:00 ET	Aranesp(R) Dosed Once Every Two Weeks Increases Hemoglobin Levels, Improves Fatigue and Reduces Need for Transfusions In Patients With Chemotherapy-Induced Anemia
05:00 ET	Novuspharma Presents Results of a Phase II Trial for BBR 3576 in Hormone Refractory Prostate Cancer at the Annual Meeting of The American Society of Clinical Oncology (ASCO)
May 31, 03
16:17 ET	Study Findings Suggest ERBITUX(TM) (Cetuximab) Activity in Patients With Advanced Non-Small Cell Lung Cancer
15:00 ET	Study Shows Age Does Not Affect Response to Prostate Cancer Treatment
14:30 ET	An EORTC Study Shows Irinotecan Enhances Standard Chemotherapy, Increasing Progression-Free Survival by 35 Percent in Colorectal Cancer Patients
14:29 ET	Interim Data From Vical's Phase II High-Dose Allovectin-7(R) Trial In Metastatic Melanoma Feature Safety, Tolerability, Efficacy And Preliminary Survival
13:31 ET	Analysis of Long-Term Response Population From BEXXAR Clinical Trials Presented at ASCO
10:15 ET	Genzyme Molecular Oncology Announces Clinical Data from Melanoma Vaccine Trial
09:00 ET	Advanced, Symptomatic Prostate Cancer Patients Treated With Abarelix, A GnRH Antagonist, Show Significant Clinical Improvement
May 30, 03
17:06 ET	SuperGen Reports Results of Phase III Study of Orathecin(TM) In Patients With Advanced Pancreatic Cancer
14:38 ET	Clinical Data on THALOMID(R) and REVIMID(TM) in Hematologic and Solid Tumor Cancers to be Presented at the American Society of Clinical Oncology
14:30 ET	Medarex Announces Upcoming MDX-010 Presentations at American Society of Clinical Oncology Meeting
13:28 ET	NCI and FDA Announce Joint Program to Streamline Cancer Drug Development
13:11 ET	Transgenomic Introduces High Sensitivity Mutation Scanning Technology To Clinical Oncology Researchers at American Society of Clinical Oncology (ASCO) Annual Meeting
13:10 ET	AstraZeneca Celebrates 25 Years of Oncology Leadership in the U.S.
12:36 ET	BioVex to Present Updated Phase I Data on Oncovex GM-CSF in Patients With Breast Cancer and Melanoma at ASCO
May 29, 03
13:05 ET	New IRESSA(R) (gefitinib) Data to Be Presented at Annual American Society Of Clinical Oncology Meeting
12:51 ET	Vital Options(R) International, OncoLink, and People Living With Cancer to Present Two Broadcasts of The Group Room(R) Cancer Talk Radio Show at ASCO Meeting on June 1
07:55 ET	American Pharmaceutical Partners to Present at Upcoming 2003 ASCO Annual Meeting and UBS Warburg Global Specialty Pharmaceutical Conference
07:30 ET	RITA Medical Systems Liver Cancer Survival Data and Lung Cancer Feasibility Data to Be Presented at ASCO
May 28, 03
13:34 ET	Vion Initiates Phase 2 Trial of Triapine(R) and Gemcitabine in Pancreatic Cancer
12:40 ET	Lights! Camera! Quit! for World No Tobacco Day
12:35 ET	Telik Announces TELCYTA(TM) Presentations at ASCO Meeting
May 27, 03
13:03 ET	New Clinical Research Data on Gleevec(TM) in Variety of Cancers Presented at American Society of Clinical Oncology (ASCO) Meeting
12:42 ET	Merck KGaA to Announce European Colorectal Cancer Study Data of Erbitux (Cetuximab) at ASCO
May 22, 03
12:48 ET	VAMC and Agennix Successfully Complete Safety Phase of Lactoferrin Cancer Trial
May 21, 03
12:51 ET	Vion Initiates Phase 2 Trial of Triapine(R) and Gemcitabine in Lung Cancer
May 19, 03
15:37 ET	American Pharmaceutical Partners Announces Positive Results in ABI-007 Clinical Studies to be Presented at the 2003 ASCO Annual Meeting
May 14, 03
13:04 ET	Novuspharma SpA Announces Financial Results for the Three Months Ended 31 March 2003
12:43 ET	Corrected SuperGen First-Quarter Financial Results